Free Trial

Xylo Technologies (MDGS) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
50-Day Range
52-Week Range
28,800 shs
Average Volume
9,658 shs
Market Capitalization
$3.92 million
P/E Ratio
Dividend Yield
Price Target
MDGS stock logo

About Xylo Technologies Stock (NASDAQ:MDGS)

Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops, produces, and markets miniaturized imaging equipment, and visualization solutions; electric vehicles; and wireless vehicle battery charging technologies. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.

MDGS Stock News Headlines

Xylo Technologies Ltd ADR
Medigus Ltd ADR MDGS
Medigus Ltd. (MDGS)
Medigus Goes a-Buyin’, Stocks Skid
Medigus Ltd.
See More Headlines
Receive MDGS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Xylo Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Fiscal Year End

Industry, Sector and Symbol

Medical Devices
Current Symbol
Year Founded


Pretax Margin


Sales & Book Value

Annual Sales
$91.86 million
Book Value
$51.82 per share


Free Float
Market Cap
$3.92 million
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Liron Carmel (Age 39)
    Chief Executive Officer
    Comp: $318k
  • Ms. Tali Dinar (Age 53)
    Chief Financial Officer
    Comp: $172k
  • Dr. Yaron Silberman (Age 54)
    Chief Executive Officer of ScoutCam Ltd.
    Comp: $172k
  • Ilan Oren
    Executive Officer

MDGS Stock Analysis - Frequently Asked Questions

Should I buy or sell Xylo Technologies stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Xylo Technologies in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" MDGS shares.
View MDGS analyst ratings
or view top-rated stocks.

When did Xylo Technologies' stock split?

Xylo Technologies's stock reverse split before market open on Monday, November 14th 2022. The 1-15 reverse split was announced on Monday, November 14th 2022. The number of shares owned by shareholders was adjusted after the market closes on Monday, November 14th 2022. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

What other stocks do shareholders of Xylo Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Xylo Technologies investors own include Bombardier (BDRBF), Advanced Micro Devices (AMD), Nuwellis (CHFS), Gevo (GEVO), Genius Brands International (GNUS), IntelGenx Technologies (IGXT), Inseego (INSG), Miragen Therapeutics (MGEN) and Naked Brand Group (NAKD).

This page (NASDAQ:MDGS) was last updated on 5/27/2024 by Staff

From Our Partners